HS Bio director and NeoGenix Lab Group managing director Dr. Kuan Chee Sian
KUALA LUMPUR: Hong Seng Consolidated Bhd
’s healthcare arm, HS Bio Sdn Bhd, has entered into a collaborative research and development (R&D) agreement with Universiti Malaysia’s Tropical Infectious Diseases Research and Education Centre (TIDREC).
The R&D agreement was done through HS Bio's wholly-subsidiary, NeoGenix Laboratoire Sdn Bhd.
Already a subscriber? Log in.
Start your ads-free experience now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
